Topical steroids versus PUVA therapy in moderate plaque psoriasis: A clinical trial along with cost analysis

Journal of Dermatological Treatment

Volumn 23, Issue 2, 2012, Pages 109-111

  Amirnia, Mehdi ^a   Khodaeiani, Effat ^a   Fouladi, Rohollah Fadaei ^b   Hashemi, Ali ^c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Dermatologist Researcher   (Germany)

Author keywords

Cost effectiveness; Psoriasis; PUVA; Steroids

Indexed keywords

EMOLLIENT AGENT; STEROID;

ADULT; ARTICLE; COMPARATIVE EFFECTIVENESS; CONSULTATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DISEASE SEVERITY; DRUG COST; FEMALE; FOLLOW UP; HUMAN; INCOME; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICATION THERAPY MANAGEMENT; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PATIENT TRANSPORT; PRIORITY JOURNAL; PSORIASIS VULGARIS; PUVA; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RECURRENT DISEASE; RELAPSE; STEROID THERAPY; TREATMENT DURATION;

ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; ADULT; FEMALE; HEALTH CARE COSTS; HUMANS; IRAN; MALE; PATIENT SATISFACTION; PSORIASIS; PUVA THERAPY; RECURRENCE; YOUNG ADULT;

EID: 84858218951     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2010.519017     Document Type: Article

References (17)

1. Burns T, Breathnach S, Cox N, Griffiths CE. Rook's textbook of dermatology. 7th ed. USA, UK, Australia: Blackwell; 2004.
2. Al-Suwaidan SN, Feldman SR. Clearance is not a realistic expectation of psoriasis treatment. J Am Acad Dermatol. 2000;42(5 Pt 1):796-802. (Pubitemid 30252885)
3. Hartman M, Prins M, Swinkels OQ, Severens JL, De Boo T, Van Der Wilt GJ, et al. Cost-effectiveness analysis of a psoriasis care instruction programme with dithranol compared with UVB phototherapy and inpatient dithranol treatment. Br J Dermatol. 2002;147(3):538-544. (Pubitemid 35015291)
4. Langan SM, Heerey A, Barry M, Barnes L. Cost analysis of narrowband UVB phototherapy in psoriasis. J Am Acad Dermatol. 2004;50(4):623-626. (Pubitemid 38393174)
5. Bolognia JL, Jorizzo JL, Rapini RP. Dermatology. USA: Mosby; 2003.
6. Yu AP, Tang J, Xie J, Wu EQ, Gupta SR, Bao Y, et al. Economic burden of psoriasis compared to the general population and stratified by disease severity. Curr Med Res Opin. 2009;25(10):2429-2438.
7. Fredriksson T, Pettersson U. Severe psoriasis-Oral therapy with a new retinoid. Dermatologica. 1978;157(4):238-244. (Pubitemid 8387357)
8. Sander HM, Morris LF, Phillips CM, Harrison PE, Menter A. The annual cost of psoriasis. J Am Acad Dermatol. 1993;28(3):422-425. (Pubitemid 23075257)
9. Carrascosa JM, Gardeazábal J, Pérez-Ferriols A, Alomar A, Manrique P, Jones-Caballero M, et al. Consensus document on phototherapy: PUVA therapy and narrow-band UVB therapy. Actas Dermosifiliogr. 2005;96(10):635-658. (Pubitemid 43362571)
10. Kirby B, Buckley DA, Rogers S. Large increments in psoralen-ultraviolet A (PUVA) therapy are unsuitable for fair-skinned individuals with psoriasis. Br J Dermatol. 1999; 140(4):661-666. (Pubitemid 29191385)
11. Lebwohl M, Ting PT, Koo JY. Psoriasis treatment: Traditional therapy. Ann Rheum Dis. 2005;64(suppl 2):ii83-86. (Pubitemid 40288530)
12. Spuls PI, Witkamp L, Bossuyt PM, Bos JD. A systematic review of five systemic treatments for severe psoriasis. Br J Dermatol. 1997;137(6):943-949. (Pubitemid 28011136)
13. Naldi L, Griffiths CE. Traditional therapies in the management of moderate to severe chronic plaque psoriasis: An assessment of the benefits and risks. Br J Dermatol. 2005; 152(4):597-615. (Pubitemid 40571289)
14. Griffiths CE, Clark CM, Chalmers RJ, Li Wan Po A, Williams HC. A systematic review of treatments for severe psoriasis. Health Technol Assess. 2000;4(40): 1-125.
15. Grundmann-Kollmann M, Ludwig R, Zollner TM, Ochsendorf F, Thaci D, Boehncke WH, et al. Narrowband UVB and cream psoralen-UVA combination therapy for plaque-type psoriasis. J Am Acad Dermatol. 2004;50(5): 734-739. (Pubitemid 38580552)
16. Stern RS, Armstrong RB, Anderson TF, Bickers DR, Lowe NJ, Harber L, et al. Effect of continued ultraviolet B phototherapy on the duration of remission of psoriasis: A randomized study. J Am Acad Dermatol. 1986;15(3): 546-552. (Pubitemid 16054126)
17. Hankin CS, Feldman SR, Szczotka A, Stinger RC, Fish L, Hankin DL. A cost comparison of treatments of moderate to severe psoriasis. Drug Benefit Trends. 2005;17(5): 200-214. (Pubitemid 41202134)